CN105061338A - 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system - Google Patents
3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system Download PDFInfo
- Publication number
- CN105061338A CN105061338A CN201410666864.7A CN201410666864A CN105061338A CN 105061338 A CN105061338 A CN 105061338A CN 201410666864 A CN201410666864 A CN 201410666864A CN 105061338 A CN105061338 A CN 105061338A
- Authority
- CN
- China
- Prior art keywords
- cas
- methyl
- acetate
- carboxylic acid
- ionic liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002608 ionic liquid Substances 0.000 title claims abstract description 27
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 13
- BJPNADFNSANIPF-UHFFFAOYSA-N 3-methylquinoxaline-2-carboxylic acid Chemical compound C1=CC=C2N=C(C(O)=O)C(C)=NC2=C1 BJPNADFNSANIPF-UHFFFAOYSA-N 0.000 title abstract description 20
- 238000000034 method Methods 0.000 title abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 5
- 230000007062 hydrolysis Effects 0.000 claims abstract description 4
- 238000007039 two-step reaction Methods 0.000 claims abstract description 4
- -1 2-acetyl fluoride methyl acetate Chemical compound 0.000 claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 17
- NJMWOUFKYKNWDW-UHFFFAOYSA-N 1-ethyl-3-methylimidazolium Chemical compound CCN1C=C[N+](C)=C1 NJMWOUFKYKNWDW-UHFFFAOYSA-N 0.000 claims description 8
- 229910018286 SbF 6 Inorganic materials 0.000 claims description 8
- IQQRAVYLUAZUGX-UHFFFAOYSA-N 1-butyl-3-methylimidazolium Chemical compound CCCCN1C=C[N+](C)=C1 IQQRAVYLUAZUGX-UHFFFAOYSA-N 0.000 claims description 7
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 5
- FWHGBPWLXDABOV-UHFFFAOYSA-N benzyl 2-bromo-3-oxobutanoate Chemical compound CC(=O)C(Br)C(=O)OCC1=CC=CC=C1 FWHGBPWLXDABOV-UHFFFAOYSA-N 0.000 claims description 4
- RDULEYWUGKOCMR-UHFFFAOYSA-N ethyl 2-chloro-3-oxobutanoate Chemical compound CCOC(=O)C(Cl)C(C)=O RDULEYWUGKOCMR-UHFFFAOYSA-N 0.000 claims description 4
- PVVLYVXLOBBQBK-UHFFFAOYSA-N benzyl 2-chloro-3-oxobutanoate Chemical compound CC(=O)C(Cl)C(=O)OCC1=CC=CC=C1 PVVLYVXLOBBQBK-UHFFFAOYSA-N 0.000 claims description 3
- NGJKQTAWMMZMEL-UHFFFAOYSA-N ethyl 2-bromo-3-oxobutanoate Chemical compound CCOC(=O)C(Br)C(C)=O NGJKQTAWMMZMEL-UHFFFAOYSA-N 0.000 claims description 3
- GYQRIAVRKLRQKP-UHFFFAOYSA-N methyl 2-chloro-3-oxobutanoate Chemical compound COC(=O)C(Cl)C(C)=O GYQRIAVRKLRQKP-UHFFFAOYSA-N 0.000 claims description 3
- FXZAMEPLYGXHJI-UHFFFAOYSA-N methyl 2-fluoro-3-oxobutanoate Chemical compound COC(=O)C(F)C(C)=O FXZAMEPLYGXHJI-UHFFFAOYSA-N 0.000 claims description 3
- XHUMMHPAJGZLFR-UHFFFAOYSA-N propan-2-yl 2-chloro-3-oxobutanoate Chemical compound CC(C)OC(=O)C(Cl)C(C)=O XHUMMHPAJGZLFR-UHFFFAOYSA-N 0.000 claims description 3
- SHTFQLHOTAJQRJ-UHFFFAOYSA-N ethyl 2-fluoro-3-oxobutanoate Chemical compound CCOC(=O)C(F)C(C)=O SHTFQLHOTAJQRJ-UHFFFAOYSA-N 0.000 claims description 2
- ZWBZYFBEOOKNPH-UHFFFAOYSA-N methyl 2-bromo-3-oxobutanoate Chemical compound COC(=O)C(Br)C(C)=O ZWBZYFBEOOKNPH-UHFFFAOYSA-N 0.000 claims description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 2
- HYQMWQDUTZICBY-UHFFFAOYSA-N CC=1C(=NC=2C=CCC(C2N1)=O)C(=O)O Chemical compound CC=1C(=NC=2C=CCC(C2N1)=O)C(=O)O HYQMWQDUTZICBY-UHFFFAOYSA-N 0.000 claims 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- MGDWUTQKXCZNAJ-UHFFFAOYSA-N ethyl 4-bromo-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CBr MGDWUTQKXCZNAJ-UHFFFAOYSA-N 0.000 claims 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims 1
- 229940011051 isopropyl acetate Drugs 0.000 claims 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 8
- 238000007363 ring formation reaction Methods 0.000 abstract description 8
- 230000035484 reaction time Effects 0.000 abstract description 4
- 238000005265 energy consumption Methods 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 239000013078 crystal Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000013067 intermediate product Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- IRZHLIWGVQPMHU-UHFFFAOYSA-N ethyl 3-methylquinoxaline-2-carboxylate Chemical compound C1=CC=C2N=C(C)C(C(=O)OCC)=NC2=C1 IRZHLIWGVQPMHU-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- TURHTASYUMWZCC-UHFFFAOYSA-N Olaquindox [BAN:INN] Chemical compound C1=CC=C2N([O-])C(C)=C(C(=O)NCCO)[N+](=O)C2=C1 TURHTASYUMWZCC-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229950010210 olaquindox Drugs 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000006392 deoxygenation reaction Methods 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- GZJCDQYVIXPMAW-UHFFFAOYSA-N 1,2-dichloro-3-ethenylbenzene Chemical compound ClC1=CC=CC(C=C)=C1Cl GZJCDQYVIXPMAW-UHFFFAOYSA-N 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- CKIHZSGJPSDCNC-UHFFFAOYSA-N Quindoxin Chemical compound C1=CC=C2N([O-])C=C[N+](=O)C2=C1 CKIHZSGJPSDCNC-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BGEFIJNJKJDLID-UHFFFAOYSA-N benzyl 3-methylquinoxaline-2-carboxylate Chemical compound CC1=NC2=CC=CC=C2N=C1C(=O)OCC1=CC=CC=C1 BGEFIJNJKJDLID-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- JITQMQFZFLZGNX-UHFFFAOYSA-N butyl 2-chloro-3-oxobutanoate Chemical compound CCCCOC(=O)C(Cl)C(C)=O JITQMQFZFLZGNX-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- XYSYNIFIPOUYOE-UHFFFAOYSA-N ethyl 2-iodo-3-oxobutanoate Chemical compound CCOC(=O)C(I)C(C)=O XYSYNIFIPOUYOE-UHFFFAOYSA-N 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-O melamine(1+) Chemical compound NC1=NC(N)=[NH+]C(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-O 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- DAUKHFGZJUUBQB-UHFFFAOYSA-N methyl 2-iodo-3-oxobutanoate Chemical compound IC(C(=O)OC)C(C)=O DAUKHFGZJUUBQB-UHFFFAOYSA-N 0.000 description 1
- PIMMFAGMQVADTQ-UHFFFAOYSA-N methyl 3-methylquinoxaline-2-carboxylate Chemical compound C1=CC=C2N=C(C)C(C(=O)OC)=NC2=C1 PIMMFAGMQVADTQ-UHFFFAOYSA-N 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 239000005486 organic electrolyte Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明属于化学合成技术领域,具体涉及一种新的基于离子液体系的高得率、高纯度、易操作的3-甲基-喹噁啉-2-羧酸化学合成方法:以邻苯二胺和α-卤代-β-酮酯为原料,采用离子液体作为溶剂体系和催化剂,经环化和水解两步反应,成功合成了目标产物3-甲基-喹噁啉-2-羧酸。本发明的核心是基于离子液体的溶剂特性和催化剂特性进行创新,使得环化反应室温下即可进行,产物得率和纯度都很高,且反应时间比较短,可降低能耗;同时,离子液体是一种不挥发的溶剂,能活化重复使用,可降低成本和减少对环境的污染。The invention belongs to the technical field of chemical synthesis, and specifically relates to a new high-yield, high-purity, and easy-to-operate chemical synthesis method for 3-methyl-quinoxaline-2-carboxylic acid based on an ionic liquid system: The target product 3-methyl-quinoxaline-2-carboxylic acid was successfully synthesized through two-step reactions of cyclization and hydrolysis using amine and α-halogenated-β-ketoester as raw materials, using ionic liquid as solvent system and catalyst . The core of the present invention is to innovate based on the solvent characteristics and catalyst characteristics of the ionic liquid, so that the cyclization reaction can be carried out at room temperature, the product yield and purity are high, and the reaction time is relatively short, which can reduce energy consumption; at the same time, the ionic The liquid is a non-volatile solvent, which can be activated and reused, which can reduce costs and reduce environmental pollution.
Description
技术领域 technical field
本发明属于化学合成技术领域,具体涉及一种新的基于离子液体系的高得率、高纯度、易操作的3-甲基-喹噁啉-2-羧酸化学合成方法。 The invention belongs to the technical field of chemical synthesis, and in particular relates to a new high-yield, high-purity and easy-to-operate chemical synthesis method for 3-methyl-quinoxaline-2-carboxylic acid based on an ionic liquid system.
背景技术 Background technique
近年来,我国食品安全事件频发,尤其是2008年“三聚氰胺”事件以及2011年“瘦肉精”事件等重大食品安全事件的发生,给国家形象带来负面影响,给食品行业造成严重的经济损失,给广大人民群众身体健康和生命安全带来威胁,引起了国家领导人和人民群众的高度关注。因此,为保障食品质量和安全,国家加大了对兽药残留、农药残留、非法添加物等食品安全危害因子的检测力度。 In recent years, my country's food safety incidents have occurred frequently, especially the occurrence of major food safety incidents such as the "melamine" incident in 2008 and the "clenbuterol" incident in 2011, which have negatively affected the country's image and caused serious economic damage to the food industry. The loss poses a threat to the health and life safety of the broad masses of the people, and has aroused great concern from state leaders and the people. Therefore, in order to ensure food quality and safety, the state has stepped up the detection of food safety hazard factors such as veterinary drug residues, pesticide residues, and illegal additives.
喹乙醇是一种具有抗菌促生长作用的兽药,由于其过量会在动物体内残留,具有明显的蓄积毒性和DNA损伤等毒副作用,欧盟于1999年禁止在食品源动物养殖过程中使用该药作促生长添加剂,我国于2001年和2005年分别规定喹乙醇禁用于家禽、水产和体重超过35kg猪的养殖。喹乙醇本身不稳定,在动物体内会发生代谢而无法直接检测,其代谢产物3-甲基-喹噁啉-2-羧酸是世界卫生组织和联合国粮食与农业组织食品添加剂联合专家委员会认定的喹乙醇残留标识物,2014年3月1日起我国将3-甲基-喹噁啉-2-羧酸列为必检项目(检测限为1ng/mL)。因此,开展3-甲基-喹噁啉-2-羧酸合成研究对于其半抗原合成、抗体制备以及快速检测具有重要的现实意义和应用价值。 Lalaquindox is a veterinary drug with antibacterial and growth-promoting effects. Because it will remain in the animal body in excess, it has obvious cumulative toxicity and DNA damage and other toxic and side effects. As a growth-promoting additive, my country stipulated that olaquindox was prohibited from being used in poultry, aquatic products and pig breeding with a body weight of more than 35kg in 2001 and 2005 respectively. Lalaquindox itself is unstable, and it will be metabolized in animals and cannot be directly detected. Its metabolite 3-methyl-quinoxaline-2-carboxylic acid is identified by the Joint Expert Committee on Food Additives of the World Health Organization and the Food and Agriculture Organization of the United Nations As for the residue marker of olaquindox, my country has listed 3-methyl-quinoxaline-2-carboxylic acid as a mandatory inspection item since March 1, 2014 (the detection limit is 1ng/mL). Therefore, the research on the synthesis of 3-methyl-quinoxaline-2-carboxylic acid has important practical significance and application value for its hapten synthesis, antibody preparation and rapid detection.
此前,本发明申请人基于吸电子诱导效应促进喹噁啉-1,4-二氧化物脱氧还原的机理进行创新,以喹乙醇为原料、乙醇水溶液为脱氧反应溶剂介质,经低亚硫酸钠脱氧、氢氧化钠水解两步反应成功合成了3-甲基-喹噁啉-2-羧酸,并申请了国家发明专利(一种3-甲基-喹噁啉-2-羧酸的高效化学合成方法,专利申请号:201310660750.7)。 Previously, the applicant of the present invention innovated on the mechanism of promoting the deoxygenation reduction of quinoxaline-1,4-dioxide based on the electron-withdrawing induction effect. Using olaquindox as raw material and ethanol aqueous solution as the solvent medium for the deoxygenation reaction, deoxygenated by sodium sulfite, hydrogen The two-step reaction of sodium oxide hydrolysis successfully synthesized 3-methyl-quinoxaline-2-carboxylic acid, and applied for a national invention patent (an efficient chemical synthesis method for 3-methyl-quinoxaline-2-carboxylic acid , patent application number: 201310660750.7).
本发明的核心是基于离子液体的溶剂特性和催化剂特性进行创新。离子液体是由特定的体积相对较大的有机阳离子和体积相对较小的无机阴离子构成的、在室温或近于室温下呈液态的物质,与传统的有机溶剂和电解质相比,离子液体具有以下突出优点:(1)离子液体几乎没有蒸气压、不挥发,具有作为环境友好的绿色溶剂的潜力;(2)可通过阴阳离子的设计,调节离子液体对无机化合物、有机化合物及聚合物的溶解性;(3)由于具有高极性和能溶解有机化合物及无机化合物的特性,已经有一些离子液体被作为催化剂用于有机合成;(4)由于离子液体不会形成恒沸系,有利于分离纯化后重复使用,可降低成本和减少对环境的污染。基于以上优点,离子液体作为溶剂和催化剂等方面的应用研究,正在世界范围内迅速开展。 The core of the invention is to innovate based on the solvent properties and catalyst properties of the ionic liquid. Ionic liquids are substances composed of specific relatively large organic cations and relatively small inorganic anions that are liquid at room temperature or near room temperature. Compared with traditional organic solvents and electrolytes, ionic liquids have the following properties: Outstanding advantages: (1) Ionic liquids have almost no vapor pressure and non-volatility, and have the potential to be environmentally friendly green solvents; (2) The dissolution of inorganic compounds, organic compounds, and polymers by ionic liquids can be adjusted through the design of anions and cations (3) Due to their high polarity and the ability to dissolve organic and inorganic compounds, some ionic liquids have been used as catalysts for organic synthesis; (4) Since ionic liquids do not form azeotropic systems, they are beneficial to separation Reuse after purification can reduce cost and reduce environmental pollution. Based on the above advantages, the application research of ionic liquids as solvents and catalysts is being carried out rapidly all over the world.
因此,本发明以邻苯二胺和α-卤代-β-酮酯为原料,采用离子液体作为溶剂体系和催化剂,经环化和水解两步反应,自主研发了一种新的高得率、高纯度、易操作的3-甲基-喹噁啉-2-羧酸化学合成方法。 Therefore, the present invention uses o-phenylenediamine and α-halogenated-β-ketoester as raw materials, adopts ionic liquid as solvent system and catalyst, and independently develops a new high-yield , high-purity, easy-to-operate 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method.
发明内容 Contents of the invention
本发明的目的是提供一种新的基于离子液体系的高得率、高纯度、易操作的3-甲基-喹噁啉-2-羧酸化学合成方法,满足研究和应用需求。 The purpose of the present invention is to provide a new high-yield, high-purity, and easy-to-operate chemical synthesis method for 3-methyl-quinoxaline-2-carboxylic acid based on an ionic liquid system to meet research and application requirements.
本发明的技术方案: Technical scheme of the present invention:
一种新的基于离子液体系的高得率、高纯度、易操作的3-甲基-喹噁啉-2-羧酸化学合成方法(合成路径如附图1),其步骤如下: A new high-yield, high-purity, and easy-to-operate chemical synthesis method for 3-methyl-quinoxaline-2-carboxylic acid based on an ionic liquid system (the synthetic route is shown in Figure 1), and the steps are as follows:
(1)环化反应(机理如附图2):以邻苯二胺和α-卤代-β-酮酯为原料,以离子液体为溶剂和催化剂,在室温条件、磁力搅拌下反应适当时间(用TLC指示反应终点)。反应终止后用乙醚萃取反应液,收集有机相,旋蒸浓缩后过层析柱(洗脱剂为乙酸乙酯:石油醚=1:3~1:10),洗脱液经旋蒸得到目标中间产物。萃取后剩下的离子液体通过真空干燥进行活化,使其可重复使用。 (1) Cyclization reaction (the mechanism is shown in Figure 2): o-Phenylenediamine and α-halogenated-β-ketoester are used as raw materials, ionic liquid is used as solvent and catalyst, and the reaction time is appropriate under room temperature and magnetic stirring (Reaction endpoint indicated by TLC). After the reaction was terminated, the reaction solution was extracted with ether, the organic phase was collected, concentrated by rotary evaporation, and then passed through the chromatography column (eluent was ethyl acetate:petroleum ether=1:3~1:10), and the eluent was rotary evaporated to obtain the target mid product. The remaining ionic liquid after extraction is activated by vacuum drying, making it reusable.
注: Note:
①α-卤代-β-酮酯为2-氟乙酰乙酸甲酯(CAS:80171-29-5)、2-氟乙酰乙酸乙酯(CAS:1522-41-4)、2-氟乙酰乙酸苯甲酯(CAS:139101-19-2)、2-氯乙酰乙酸甲酯(CAS:4755-81-1)、2-氯乙酰乙酸乙酯(CAS:609-15-4)、2-氯乙酰乙酸正丙酯(CAS:104517-64-8)、2-氯乙酰乙酸异丙酯(CAS:70697-72-2)、2-氯乙酰乙酸正丁酯(CAS:90089-91-1)、2-氯乙酰乙酸异丁酯(CAS:85153-47-5)、2-氯乙酰乙酸苯甲酯(CAS:104517-65-9)、2-溴乙酰乙酸甲酯(CAS:3600-18-8)、2-溴乙酰乙酸乙酯(CAS:609-13-2)、2-溴乙酰乙酸苯甲酯(CAS:362610-29-5)、2-碘乙酰乙酸甲酯(CAS:1017883-28-1)、2-碘乙酰乙酸乙酯(CAS:104790-31-5)或2-碘乙酰乙酸苯甲酯(CAS:1017883-41-8)。 ① α-halo-β-ketoesters are methyl 2-fluoroacetoacetate (CAS: 80171-29-5), ethyl 2-fluoroacetoacetate (CAS: 1522-41-4), benzene 2-fluoroacetoacetate Methyl ester (CAS: 139101-19-2), methyl 2-chloroacetoacetate (CAS: 4755-81-1), ethyl 2-chloroacetoacetate (CAS: 609-15-4), 2-chloroacetyl n-Propyl acetate (CAS: 104517-64-8), isopropyl 2-chloroacetoacetate (CAS: 70697-72-2), n-butyl 2-chloroacetoacetate (CAS: 90089-91-1), Isobutyl 2-chloroacetoacetate (CAS: 85153-47-5), Benzyl 2-chloroacetoacetate (CAS: 104517-65-9), Methyl 2-bromoacetoacetate (CAS: 3600-18- 8), ethyl 2-bromoacetoacetate (CAS: 609-13-2), benzyl 2-bromoacetoacetate (CAS: 362610-29-5), methyl 2-iodoacetoacetate (CAS: 1017883- 28-1), ethyl 2-iodoacetoacetate (CAS: 104790-31-5) or benzyl 2-iodoacetoacetate (CAS: 1017883-41-8).
②离子液体为[MIM][PF6]、[EMIM][PF6]、[PMIM][PF6]、[BMIM][PF6]、[MIM][SbF6]、[EMIM][SbF6]、[PMIM][SbF6]、[BMIM][SbF6]、[MIM][BF4]、[EMIM][BF4]、[PMIM][BF4]或[BMIM][BF4]。 ② The ionic liquids are [MIM][PF 6 ], [EMIM][PF 6 ], [PMIM][PF 6 ], [BMIM][PF 6 ], [MIM][SbF 6 ], [EMIM][SbF 6 ], [PMIM][SbF 6 ], [BMIM][SbF 6 ], [MIM][BF 4 ], [EMIM][BF 4 ], [PMIM][BF 4 ] or [BMIM][BF 4 ].
③目标中间产物为3-甲基-喹噁啉-2-甲酸甲酯、3-甲基-喹噁啉-2-甲酸乙酯、3-甲基-喹噁啉-2-甲酸正丙酯、3-甲基-喹噁啉-2-甲酸异丙酯、3-甲基-喹噁啉-2-甲酸正丁酯、3-甲基-喹噁啉-2-甲酸异丁酯或3-甲基-喹噁啉-2-甲酸苯甲酯。 ③Target intermediate products are 3-methyl-quinoxaline-2-carboxylic acid methyl ester, 3-methyl-quinoxaline-2-carboxylic acid ethyl ester, 3-methyl-quinoxaline-2-carboxylic acid n-propyl ester , 3-methyl-quinoxaline-2-carboxylic acid isopropyl ester, 3-methyl-quinoxaline-2-carboxylic acid n-butyl ester, 3-methyl-quinoxaline-2-carboxylic acid isobutyl ester or 3 -Methyl-quinoxaline-2-carboxylic acid benzyl ester.
(2)水解反应:以上述得到的中间产物为原料,添加5%-20%的氢氧化钠水溶液,加热、搅拌下水解1-6小时,反应完毕后反应液冷却至室温,用盐酸溶液调节pH值(pH为1-7)。然后用二氯甲烷萃取反应液,收集有机相,加入无水硫酸钠进行干燥,通过旋蒸得到的粗品再用乙酸乙酯(或甲醇)重结晶,得到类白色晶体。 (2) Hydrolysis reaction: use the intermediate product obtained above as raw material, add 5%-20% sodium hydroxide aqueous solution, heat and stir for 1-6 hours, and cool the reaction solution to room temperature after the reaction is completed, adjust with hydrochloric acid solution pH (pH 1-7). Then extract the reaction solution with dichloromethane, collect the organic phase, add anhydrous sodium sulfate for drying, and recrystallize the crude product obtained by rotary evaporation with ethyl acetate (or methanol) to obtain off-white crystals.
(3)上述类白色晶体进行高效液相色谱测定,高效液相色谱条件为:色谱柱:C18反相柱,250mm×4.6μm(内径),粒径5μm;流动相:1%甲酸水溶液+乙腈(75+25);流速:0.5mL/min;检测波长:320nm;进样量:20μL;柱温:30℃。色谱图显示只有1个主峰,无杂质峰,证明其为纯物质,纯度非常高。 (3) The above-mentioned off-white crystals were determined by high-performance liquid chromatography, and the high-performance liquid chromatography conditions were: chromatographic column: C18 reversed-phase column, 250mm×4.6μm (inner diameter), particle size 5μm; mobile phase: 1% formic acid aqueous solution + acetonitrile (75+25); flow rate: 0.5mL/min; detection wavelength: 320nm; injection volume: 20μL; column temperature: 30°C. The chromatogram shows only one main peak and no impurity peaks, proving that it is a pure substance with a very high purity.
(4)对上述类白色晶体进行质谱和核磁共振鉴定,质谱条件:电喷雾电离,负离子化模式;干燥气温度:350℃;干燥气流速:8.00L/min;毛细管出口电压:-88.5V;毛细管入口电压:-20.3V;扫描范围:m/z为50-500。核磁共振条件:1HNMR:溶剂:DMSO;共振频率:300.13MHZ。通过高效液相色谱-质谱联用鉴定以及核磁共振鉴定,确定上述类白色晶体为目标产物3-甲基-喹噁啉-2-羧酸。 (4) Perform mass spectrometry and nuclear magnetic resonance identification on the above-mentioned off-white crystals, mass spectrometry conditions: electrospray ionization, negative ionization mode; drying gas temperature: 350°C; drying gas flow rate: 8.00L/min; capillary outlet voltage: -88.5V; Capillary entrance voltage: -20.3V; scanning range: m/z is 50-500. NMR conditions: 1 HNMR: solvent: DMSO; resonance frequency: 300.13MH Z . Through high-performance liquid chromatography-mass spectrometry identification and nuclear magnetic resonance identification, it was determined that the above-mentioned off-white crystals were the target product 3-methyl-quinoxaline-2-carboxylic acid.
本发明具有以下优点: The present invention has the following advantages:
1、产物得率和纯度高:本发明采用离子液体作为溶剂体系和催化剂,充分保证环化反应的发生和产物的唯一性,从而获得高得率、高纯度的3-甲基-喹噁啉-2-羧酸。 1. High product yield and purity: the present invention uses ionic liquid as a solvent system and catalyst to fully ensure the occurrence of cyclization reaction and the uniqueness of the product, thereby obtaining high yield and high purity 3-methyl-quinoxaline -2-Carboxylic acid.
2、操作简单,反应时间短:本发明仅需环化和水解两步反应,采用磁力搅拌器、旋转蒸发仪等实验室常见设备,操作方法非常简单。同时,环化反应仅需40-90min,与3-甲基-喹噁啉-2-羧酸其他合成方法需要好几个小时相比,缩短了反应时间。 2. Simple operation and short reaction time: the present invention only needs two-step reactions of cyclization and hydrolysis, and uses common laboratory equipment such as magnetic stirrer and rotary evaporator, and the operation method is very simple. At the same time, the cyclization reaction only needs 40-90 minutes, which shortens the reaction time compared with the several hours required by other synthetic methods of 3-methyl-quinoxaline-2-carboxylic acid.
3、成本低,污染小:由于离子液体不会形成恒沸系,有利于活化后重复使用,可降低成本和减少对环境的污染。同时,离子液体几乎没有蒸气压、不挥发,具有作为环境友好的绿色溶剂的潜力,对环境的污染小。 3. Low cost and low pollution: Since the ionic liquid does not form an azeotropic system, it is conducive to repeated use after activation, which can reduce costs and reduce environmental pollution. At the same time, ionic liquids have almost no vapor pressure and are non-volatile, so they have the potential to be environmentally friendly green solvents with little pollution to the environment.
4、能耗低:本发明的环化反应是在室温条件下进行,与3-甲基-喹噁啉-2-羧酸其他合成方法需要加热相比,可降低能耗。 4. Low energy consumption: the cyclization reaction of the present invention is carried out at room temperature, which can reduce energy consumption compared with other synthesis methods of 3-methyl-quinoxaline-2-carboxylic acid that require heating.
附图说明 Description of drawings
图1是本发明3-甲基-喹噁啉-2-羧酸的合成路径; Fig. 1 is the synthetic route of 3-methyl-quinoxaline-2-carboxylic acid of the present invention;
图2是本发明的环化反应机理; Fig. 2 is the cyclization reaction mechanism of the present invention;
图3是本发明实施例1(3a)和实施例3(3b)合成产物的高效液相色谱图; Fig. 3 is the high performance liquid phase chromatogram of the synthetic product of embodiment 1 (3a) and embodiment 3 (3b) of the present invention;
图4是本发明合成的3-甲基-喹噁啉-2-羧酸质谱图; Fig. 4 is the 3-methyl-quinoxaline-2-carboxylic acid mass spectrum that the present invention synthesizes;
图5是本发明合成的3-甲基-喹噁啉-2-羧酸1HNMR谱图。 Fig. 5 is the 1 H NMR spectrum of 3-methyl-quinoxaline-2-carboxylic acid synthesized in the present invention.
具体实施方式 Detailed ways
实施例1Example 1
(1)向反应试管中加入0.216g(2mmol)邻苯二胺、0.361g(2.2mmol)2-氯乙酰乙酸乙酯和4mL[EMIM][BF4],室温下磁力搅拌反应60min(通过TLC监测反应终点确定)。用3×15mL乙醚萃取反应液,收集有机相,旋蒸浓缩后进行柱层析(洗脱剂为乙酸乙酯:石油醚=1:9),洗脱液经旋蒸得到目标中间产物3-甲基-喹噁啉-2-甲酸乙酯,称重为0.389g,得率达90%。萃取后剩下的离子液体通过真空干燥进行活化,使其可重复使用。 (1) Add 0.216g (2mmol) o-phenylenediamine, 0.361g (2.2mmol) ethyl 2-chloroacetoacetate and 4mL [EMIM][BF4] to the reaction test tube, and stir the reaction with magnetic force for 60min at room temperature (monitored by TLC The end point of the reaction is determined). The reaction solution was extracted with 3×15mL ether, the organic phase was collected, concentrated by rotary evaporation, and then subjected to column chromatography (eluent: ethyl acetate:petroleum ether=1:9), and the eluent was rotary evaporated to obtain the target intermediate product 3- Methyl-quinoxaline-2-carboxylic acid ethyl ester weighs 0.389g, and the yield reaches 90%. The remaining ionic liquid after extraction is activated by vacuum drying, making it reusable.
(2)往50mL三口圆底烧瓶中加入上述制备的3-甲基-喹噁啉-2-甲酸乙酯0.216g和10%氢氧化钠溶液15mL,90℃搅拌下反应2h,停止反应后冷却至室温,用稀盐酸调节反应液pH值至5。反应液用3×15mL二氯甲烷萃取,收集有机相,无水硫酸钠干燥后旋蒸得固体,然后用甲醇重结晶,得到类白色晶体0.152g。 (2) Add 0.216g of ethyl 3-methyl-quinoxaline-2-carboxylate prepared above and 15mL of 10% sodium hydroxide solution into a 50mL three-neck round bottom flask, react at 90°C for 2h, stop the reaction and then cool to room temperature, and adjust the pH value of the reaction solution to 5 with dilute hydrochloric acid. The reaction solution was extracted with 3×15 mL of dichloromethane, the organic phase was collected, dried over anhydrous sodium sulfate and then rotary evaporated to obtain a solid, which was then recrystallized with methanol to obtain 0.152 g of off-white crystals.
(3)上述类白色晶体进行高效液相色谱测定,高效液相色谱条件为:色谱柱:C18反相柱,250mm×4.6μm(内径),粒径5μm;流动相:1%甲酸水溶液+乙腈(75+25);流速:0.5mL/min;检测波长:320nm;进样量:20μL;柱温:30℃。如附图3a,类白色晶体色谱图只有1个主峰,无其他杂质峰,证明其为纯物质,纯度非常高。 (3) The above-mentioned off-white crystals were determined by high performance liquid chromatography. The high performance liquid chromatography conditions were as follows: chromatographic column: C18 reversed-phase column, 250mm×4.6μm (inner diameter), particle size 5μm; mobile phase: 1% formic acid aqueous solution + acetonitrile (75+25); flow rate: 0.5mL/min; detection wavelength: 320nm; injection volume: 20μL; column temperature: 30°C. As shown in Figure 3a, the off-white crystal chromatogram has only one main peak and no other impurity peaks, proving that it is a pure substance with very high purity.
实施例2Example 2
使用实施例1中活化后的[EMIM][BF4],完全按照实施例1的操作方案进行实施,第一步反应得到目标中间产物3-甲基-喹噁啉-2-甲酸乙酯,称重为0.379g,得率达88%。实施例2充分证明了离子液体经本发明的活化操作,完全可以重复使用。 Use [EMIM][BF4] after activation in Example 1, implement completely according to the operating scheme of Example 1, the first step reaction obtains target intermediate product 3-methyl-quinoxaline-2-carboxylic acid ethyl ester, weighs The weight is 0.379g, and the yield is 88%. Example 2 fully proves that the ionic liquid can be completely reused after the activation operation of the present invention.
实施例3Example 3
(1)向反应试管中加入0.216g(2mmol)邻苯二胺、0.542g(2.2mmol)2-溴乙酰乙酸苯甲酯和4mL[BMIM][PF6],室温下磁力搅拌搅拌反应50min(通过TLC监测反应终点确定)。用3×15mL乙醚萃取反应液,收集有机相,旋蒸浓缩后进行柱层析(洗脱剂为乙酸乙酯:石油醚=1:9),洗脱液经旋蒸得到目标中间产物3-甲基-喹噁啉-2-甲酸苯甲酯,称重为0.493g,产率达87%。 (1) Add 0.216g (2mmol) o-phenylenediamine, 0.542g (2.2mmol) benzyl 2-bromoacetoacetate and 4mL [BMIM][PF 6 ] into the reaction test tube, and stir the reaction with magnetic stirring for 50min at room temperature ( The end point of the reaction was monitored by TLC). The reaction solution was extracted with 3×15mL ether, the organic phase was collected, concentrated by rotary evaporation, and then subjected to column chromatography (eluent: ethyl acetate:petroleum ether=1:9), and the eluent was rotary evaporated to obtain the target intermediate product 3- Benzyl methyl-quinoxaline-2-carboxylate, weighing 0.493 g, yielded 87%.
(2)往50mL三口圆底烧瓶中加入上述制备的3-甲基-喹噁啉-2-甲酸苯甲酯0.278g和5%氢氧化钠溶液15mL,回流反应1h,停止反应后冷却至室温,用3×10mL乙醚萃取苯甲醇。水相用稀盐酸调节pH值至5,用3×15mL二氯甲烷萃取,收集有机相,无水硫酸钠干燥后旋蒸得固体,然后用乙酸乙酯重结晶,得到类白色晶体0.147g。 (2) Add 0.278 g of the above-prepared 3-methyl-quinoxaline-2-benzoic acid benzyl ester and 15 mL of 5% sodium hydroxide solution into a 50 mL three-neck round bottom flask, reflux for 1 hour, stop the reaction and cool to room temperature , Benzyl alcohol was extracted with 3×10 mL ether. The pH of the aqueous phase was adjusted to 5 with dilute hydrochloric acid, extracted with 3×15 mL of dichloromethane, the organic phase was collected, dried over anhydrous sodium sulfate and rotary evaporated to obtain a solid, which was then recrystallized with ethyl acetate to obtain 0.147 g of off-white crystals.
(3)上述类白色晶体进行高效液相色谱测定,高效液相色谱条件同实施例1。如附图3b,类白色晶体色谱图只有1个主峰,无其他杂质峰,证明其为纯物质,纯度非常高。 (3) The above-mentioned off-white crystals are measured by high performance liquid chromatography, and the conditions of high performance liquid chromatography are the same as those in Example 1. As shown in Figure 3b, the off-white crystal chromatogram has only one main peak and no other impurity peaks, proving that it is a pure substance with very high purity.
实施例4Example 4
对实施例1和实施例3的终产物进行鉴定。 The final products of Example 1 and Example 3 were identified.
质谱条件:电喷雾电离,负离子化模式;干燥气温度:350℃;干燥气流速:8.00L/min;毛细管出口电压:-88.5V;毛细管入口电压:-20.3V;扫描范围:m/z为50-500。 Mass spectrometry conditions: electrospray ionization, negative ionization mode; drying gas temperature: 350°C; drying gas flow rate: 8.00L/min; capillary outlet voltage: -88.5V; capillary inlet voltage: -20.3V; scan range: m/z 50-500.
核磁共振条件:1HNMR:溶剂:DMSO;共振频率:300.13MHZ。 NMR conditions: 1 HNMR: solvent: DMSO; resonance frequency: 300.13MH Z .
通过高效液相色谱-质谱联用鉴定(如附图4)以及核磁共振鉴定(1H核磁谱图如附图5),确定实施例1和实施例3最终获得的类白色晶体均为3-甲基-喹噁啉-2-羧酸。 Through high-performance liquid chromatography-mass spectrometry identification (as shown in Figure 4) and NMR identification ( 1H NMR spectrum as shown in Figure 5), it is determined that the off-white crystals finally obtained in Example 1 and Example 3 are all 3- Methyl-quinoxaline-2-carboxylic acid.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410666864.7A CN105061338A (en) | 2014-11-20 | 2014-11-20 | 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410666864.7A CN105061338A (en) | 2014-11-20 | 2014-11-20 | 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105061338A true CN105061338A (en) | 2015-11-18 |
Family
ID=54490907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410666864.7A Pending CN105061338A (en) | 2014-11-20 | 2014-11-20 | 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105061338A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110218195A (en) * | 2018-03-02 | 2019-09-10 | 上海安谱实验科技股份有限公司 | A kind of quinoxaline -2- the carboxylic acid and its synthetic method of stable isotope labeling |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043292A1 (en) * | 2003-08-20 | 2005-02-24 | Pfizer Inc | Fluorinated lysine derivatives as dipeptidyl peptidase IV inhibitors |
CN101012202A (en) * | 2007-01-26 | 2007-08-08 | 华中农业大学 | Method of preparing 3-methylquinoxaline-2-carboxylic acid |
CN101016267A (en) * | 2007-01-26 | 2007-08-15 | 华中农业大学 | Chemical synthesis method for 3-methylquinoxaline-2-carboxylic acid |
CN101108829A (en) * | 2007-01-29 | 2008-01-23 | 江南大学 | A kind of preparation method of 3-methyl-quinoline-2-carboxylic acid |
CN102311414A (en) * | 2011-07-01 | 2012-01-11 | 广东石油化工学院 | Method for synthesizing 7-hydroxy-4-methylcoumarin with solvent-free catalysis of ionic liquid |
CN103420927A (en) * | 2013-06-07 | 2013-12-04 | 华中农业大学 | Synthetic method of quinoxaline-2-carboxylic acid |
JP2014118357A (en) * | 2012-12-13 | 2014-06-30 | Mitsubishi Tanabe Pharma Corp | Method of producing substituted pyrazolopyrimidine compound, and synthetic intermediate thereof |
-
2014
- 2014-11-20 CN CN201410666864.7A patent/CN105061338A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043292A1 (en) * | 2003-08-20 | 2005-02-24 | Pfizer Inc | Fluorinated lysine derivatives as dipeptidyl peptidase IV inhibitors |
CN101012202A (en) * | 2007-01-26 | 2007-08-08 | 华中农业大学 | Method of preparing 3-methylquinoxaline-2-carboxylic acid |
CN101016267A (en) * | 2007-01-26 | 2007-08-15 | 华中农业大学 | Chemical synthesis method for 3-methylquinoxaline-2-carboxylic acid |
CN101108829A (en) * | 2007-01-29 | 2008-01-23 | 江南大学 | A kind of preparation method of 3-methyl-quinoline-2-carboxylic acid |
CN102311414A (en) * | 2011-07-01 | 2012-01-11 | 广东石油化工学院 | Method for synthesizing 7-hydroxy-4-methylcoumarin with solvent-free catalysis of ionic liquid |
JP2014118357A (en) * | 2012-12-13 | 2014-06-30 | Mitsubishi Tanabe Pharma Corp | Method of producing substituted pyrazolopyrimidine compound, and synthetic intermediate thereof |
CN103420927A (en) * | 2013-06-07 | 2013-12-04 | 华中农业大学 | Synthetic method of quinoxaline-2-carboxylic acid |
Non-Patent Citations (5)
Title |
---|
Carbonyl-Enamine a New Mode for Azepine Ring Closure: Synthesis and Characterization of Pyrazino[2,3-c]azepine, as a New Ring System;Mohamed Attia Waly;《Acta Chim. Slov.》;20081231;第55卷(第2期);第343-349页 * |
CeCl3.7H2O-catalyzed synthesis of quinoxaline derivatives in liquid PEG-400;Fang-Wen Wu,等;《Heterocycles》;20111231;第83卷(第10期);第2313-2320页 * |
One-pot synthesis of quinoxaline-2-carboxylate derivatives using ionic liquid as reusable reaction media;H.M.Meshram,等;《Tetrahedron Letters》;20100602;第51卷(第33期);第4313-4316页 * |
Synthesis of the possible metabolites of quinocetone in animals;Jian-yong Li,等;《Heterocyclic Communications》;20071231;第13卷(第1期);第49-56页 * |
咪唑盐二醋酸碘苯促进苯并咪唑类衍生物的水相合成;王孝科,等;《高等学校化学学报》;20100228;第31卷(第02期);第296-302页 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110218195A (en) * | 2018-03-02 | 2019-09-10 | 上海安谱实验科技股份有限公司 | A kind of quinoxaline -2- the carboxylic acid and its synthetic method of stable isotope labeling |
CN110218195B (en) * | 2018-03-02 | 2022-08-09 | 上海安谱实验科技股份有限公司 | Stable isotope labeled quinoxaline-2-carboxylic acid and synthesis method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hajjami et al. | Incredible role of glycerol in multicomponent synthesis of 2, 3-dihydroquinazoline-4 (1H)-ones and 1-amidoalkyl-2-naphthols | |
Deng et al. | Brønsted acid ionic liquid [Et3NH][HSO4] as an efficient and reusable catalyst for the synthesis of 2, 4, 5-triaryl-1H-imidazoles | |
CN105037381A (en) | Green catalytic preparation method of pyrano[4,3-b]pyran derivative | |
CN105801595A (en) | Method for catalytically preparing 4,5-dihydropyran[c]chromene derivative | |
CN105218486A (en) | A kind of method preparing epoxy chloropropane and calcium chloride | |
CN106518726B (en) | Aryl Schiff base derivative and preparation method and application thereof | |
CN105061338A (en) | 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system | |
CN104326987B (en) | The method of a kind of aqueous catalysis synthesis 2,4,5-triaryl-1H-imdazole derivatives | |
CN104086525B (en) | A kind of there is anti-microbial activity spiral shell [tetralone-tetramethylene sulfide] derivative and synthetic method and application | |
CN103113174B (en) | Preparation method of phenolic compounds | |
CN105523909A (en) | Method for preparing alpha and beta-unsaturated ketone | |
CN107501120B (en) | A kind of preparation method of 3-aminobutanamide compound | |
CN103880776A (en) | Method for preparing 2-amino-5-alkyl-1,3,4-thiadiazole | |
CN102627548B (en) | Method for reclaiming acetone and acetic acid in waste solvent in isopropylidene production process | |
CN104059036B (en) | A kind of synthetic method of 5-[(dimethylamino) methyl]-2-furfuralcohol | |
CN104130190B (en) | A kind of synthetic method of pyrazole derivatives | |
CN104945376A (en) | synthesizing method for 3-aroyl indole compound | |
CN105001176B (en) | A kind of preparation method of 2 oxazolinone derivant | |
CN109293507B (en) | Synthetic method and application of dimethyl 4-methoxymethylene-2-eneglutarate | |
CN105384658B (en) | A kind of method for synthesizing anise nitrile | |
CN104693131A (en) | Efficient chemical synthesizing method of 3-methyl-quinoxaline-2-carboxylic acid | |
CN107011286A (en) | It is a kind of that the amide compound of structure containing saccharin is dehydrated to the method that nitrile is made | |
CN108658891A (en) | 2- Thioxothiazolidin -4- ketone, derivative and preparation method thereof | |
CN104086507A (en) | Preparation method of N-formyl phenothiazine | |
CN104628640A (en) | Preparation method of compound 6-fluorine-4-hydroxyquinoline-3-carboxylic ethyl ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151118 |
|
WD01 | Invention patent application deemed withdrawn after publication |